TP53 and astrocytoma (excluding glioblastoma): Taken together, in the predominantly oligodendroglial differentiated tumors TP53- mutations were evenly distributed between the tumor components reminiscent of oligodendroglioma and astrocytoma (n = 3/9; 33%).